Pancreatic Diseases D010182

Diseases [C] » Digestive System Diseases [C06] » Pancreatic Diseases

Description

Pathological processes of the PANCREAS.   MeSH

Subtype Terms (7)

Congenital Hyperinsulinism
17 drugs (13 approved, 4 experimental)

Cystic Fibrosis
293 drugs (140 approved, 153 experimental)

Exocrine Pancreatic Insufficiency
23 drugs (12 approved, 11 experimental)

Pancreatic Cyst
3 approved drugs

Pancreatic Fistula
7 drugs (6 approved, 1 experimental)

Pancreatic Neoplasms
987 drugs (301 approved, 686 experimental)

Pancreatitis
87 drugs (63 approved, 24 experimental)


Approved Indicated Drugs (2)


Organization Involved with Phase 4 Indications (3)

Organization Involved with Phase 2 Indications (4)

Organization Involved with Phase 1 Indications (3)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.